Adam Mendelsohn
Co-Founder & Chief Executive Officer Vivani
Seminars
Wednesday 9th December 2026
Beyond Weekly Injections: Reimagining Long-Term Obesity Treatment Through Ultra-Long-Acting Drug Delivery
2:00 pm
- Examining how poor adherence and early treatment discontinuation contribute to suboptimal outcomes and rapid weight regain
- Exploring whether continuous, long-acting drug exposure can improve tolerability and persistence by reducing fluctuations associated with missed doses
- Evaluating the potential of reversible implant-based therapies to deliver durable efficacy with minimal patient burden while maintaining treatment flexibility and control
Wednesday 9th December 2026
Fireside Chat: Aligning Route & Frequency of Administration with Real-World Patient Needs & Treatment Goals
2:40 pm
- How do patient preferences differ across daily oral, weekly injectable, monthly injectable, and long acting therapies, and what factors most influence modality selection?
- How should developers balance the convenience of long-acting treatments against the safety and practical considerations associated with pregnancy, adverse events, surgical procedures, and changing patient circumstances?
- What is the optimal dosing frequency, to maximize adherence and persistence while sufficient flexibility for dose adjustments, treatment interruptions and treatment discontinuation when needed?
